RADIATION SENSITIVITIES IN VARIOUS ANTICANCER-DRUG-RESISTANT HUMAN LUNG-CANCER CELL-LINES AND MECHANISM OF RADIATION CROSS-RESISTANCE IN A CISPLATIN-RESISTANT CELL-LINE

被引:24
|
作者
OSHITA, F
FUJIWARA, Y
SAIJO, N
机构
[1] NATL CANC CTR,DEPT INTERNAL MED,TOKYO 104,JAPAN
[2] NAGASAKI UNIV,SCH MED,DEPT INTERNAL MED 2,NAGASAKI 852,JAPAN
[3] NATL CANC CTR,RES INST,DIV PHARMACOL,CHUO KU,TOKYO,JAPAN
关键词
RADIATION SENSITIVITY; DRUG RESISTANCE; LUNG CANCER; GLUTATHIONE; CISPLATIN; ETOPOSIDE; CAMPTOTHECIN;
D O I
10.1007/BF01209484
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To determine whether there exists cross-resistance between anticancer drugs and radiation, six drug-resistant human lung cancer cell lines and their parental cell lines were examined for radiosensitivity using a growth-inhibition assay. Only one cisplatin-resistant cell line, PC-9/CDDP, showed cross-resistance to radiation. The other three cisplatin-resistant cell lines (PC-7/CDDP, PC-4/CDDP, and H69/CDDP), an etoposide-resistant cell line (H69/VP) and a camptothecin-resistant cell line (PC-7/CPT) did not show cross-resistance to radiation. To analyze the mechanism of radiation resistance in PC-9/CDDP cells. the formation and repair of radiation-induced DNA single-strand breaks (ssb) and double-strand breaks (dsb) were examined by alkaline elution and neutral elution respectively. Although the formation of DNA ssb and repair of both DNA ssb and DNA dsb were the same for both cell lines, the formation of DNA dsb in PC-9/CDDP cells was significantly less than those in PC-9 cells. Measurement of intracellular glutathione content in all of the cell lines revealed that only PC-9/CDDP cells had a significant increase of glutathione content compared to the parental cells. Buthionine sulfoximine treatment of PC-9/CDDP cells caused an increase of DNA dsb to the same levels as in PC-9 cells after irradiation and caused a complete radiosensitization. These results indicate that cross-resistance to radiation in drug-resistant cells in a rare phenomenon, and increased glutathione content may play a crucial role in the emergence of cross-resistance to radiation in the drug-resistant cells.
引用
收藏
页码:28 / 34
页数:7
相关论文
共 50 条
  • [41] ESTABLISHMENT AND CHARACTERIZATION OF AN ETOPOSIDE-RESISTANT HUMAN SMALL-CELL LUNG-CANCER CELL-LINE
    TAKIGAWA, N
    OHNOSHI, T
    UEOKA, H
    KIURA, K
    KIMURA, I
    [J]. ACTA MEDICA OKAYAMA, 1992, 46 (03) : 203 - 212
  • [42] Biochemical mechanism of cross-resistance to paclitaxel in a mitomycin c-resistant human bladder cancer cell line
    Bleicher, RJ
    Xia, H
    Zaren, HA
    Singh, SV
    [J]. CANCER LETTERS, 2000, 150 (02) : 129 - 135
  • [43] Effect and mechanism of Src tyrosine kinase inhibitor sunitinib on the drug-resistance reversal of human A549/DDP cisplatin-resistant lung cancer cell line
    Zhang, Ke
    Wang, Xian
    Wang, Hongyan
    [J]. MOLECULAR MEDICINE REPORTS, 2014, 10 (04) : 2065 - 2072
  • [44] ESTABLISHMENT OF A CAMPTOTHECIN ANALOG (CPT-11)-RESISTANT CELL-LINE OF HUMAN NON-SMALL CELL LUNG-CANCER - CHARACTERIZATION AND MECHANISM OF RESISTANCE
    KANZAWA, F
    SUGIMOTO, Y
    MINATO, K
    KASAHARA, K
    BUNGO, M
    NAKAGAWA, K
    FUJIWARA, Y
    LIU, LF
    SAIJO, N
    [J]. CANCER RESEARCH, 1990, 50 (18) : 5919 - 5924
  • [45] ESTABLISHMENT OF AN ETOPOSIDE-RESISTANT HUMAN EPITHELIAL TUMOR-CELL LINE INVITRO - CHARACTERIZATION OF PATTERNS OF CROSS-RESISTANCE AND DRUG SENSITIVITIES
    HILL, BT
    BELLAMY, AS
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (05) : 599 - 608
  • [46] THE MECHANISM OF THE DIFFERENCE IN CELLULAR UPTAKE OF PLATINUM DERIVATIVES IN NONSMALL CELL LUNG-CANCER CELL-LINE (PC-14) AND ITS CISPLATIN-RESISTANT SUBLINE (PC-14/CDDP)
    OHMORI, T
    MORIKAGE, T
    SUGIMOTO, Y
    FUJIWARA, Y
    KASAHARA, K
    NISHIO, K
    OHTA, S
    SASAKI, Y
    TAKAHASHI, T
    SAIJO, N
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (01): : 83 - 92
  • [47] THE ROLE OF METHOXYMORPHOLINO ANTHRACYCLINE AND CYANOMORPHOLINO ANTHRACYCLINE IN A SENSITIVE SMALL-CELL LUNG-CANCER CELL-LINE AND ITS MULTIDRUG-RESISTANT BUT P-GLYCOPROTEIN-NEGATIVE AND CISPLATIN-RESISTANT COUNTERPARTS
    VANDERGRAAF, WTA
    MULDER, NH
    MEIJER, C
    DEVRIES, EGE
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 35 (04) : 345 - 348
  • [48] Cross-resistance to ON01910.Na among drug-resistant human tumor cell lines
    Preda, Adrian
    Ohnuma, Takao
    Jiang, Jian-Dong
    Holland, James F.
    Reddy, E. Premkumar
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [49] Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines
    Radosław Januchowski
    Karolina Sterzyńska
    Katarzyna Zaorska
    Patrycja Sosińska
    Andrzej Klejewski
    Maciej Brązert
    Michał Nowicki
    Maciej Zabel
    [J]. Journal of Ovarian Research, 9
  • [50] Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines
    Januchowski, Radoslaw
    Sterzynska, Karolina
    Zaorska, Katarzyna
    Sosinska, Patrycja
    Klejewski, Andrzej
    Brazert, Maciej
    Nowicki, Michal
    Zabel, Maciej
    [J]. JOURNAL OF OVARIAN RESEARCH, 2016, 9 : 1 - 11